Protea Biosciences Balance Sheet - Annual (OTCMKTS:PRGBQ)

Add to My Stocks
$0.01 $0 (0%) PRGBQ stock closing price Sep 21, 2018 (Closing)

A thorough fundamental analysis involves using data from Protea Biosciences balance sheet, apart from other financial statements, to value the business. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Protea Biosciences stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Protea Biosciences revenue Protea Biosciences operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Protea Biosciences balance sheet for 2016 shows cash on hand of $-. The company has a debt to equity ratio of .

View latest 10 year balance sheet data to check Protea Biosciences financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011
Cash---1.08M--
Marketable Securities------
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets------
Total Current Assets
---2.5M1.39M1.31M
Property Plant & Equipment6.65M7.56M8.51M7.91M7.03M6.56M
Accumulated Depreciation4.18M4.93M5.55M5.02M4.24M3.24M
Net Property Plant & Equipment
2.46M2.62M2.96M2.88M2.79M3.31M
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
3.21M3.04M4.02M5.41M4.21M4.64M
Notes Payable------
Accounts Payable1.79M1.33M1.25M-2.27M2.5M
Current Portion Long-Term Debt10.1M6.89M5.83M4.39M6.99M4.14M
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities3.65M1.35M-1.06M--
Total Current Liabilities
15.55M9.59M7.76M6.22M10.03M6.96M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt1.76M1.72M1.81M1.58M2.08M2.18M
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
17.31M11.32M9.58M8.42M12.11M9.15M
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus81.12M71.31M64.3M55.35M39.07M32.92M
Retained Earnings-95.24M-79.59M-69.86M-58.39M-46.97M-37.44M
Treasury Stock------
Other Liabilities-----0.01M-
Shareholders Equity-14.1M-8.27M-5.55M-3.01M-7.9M-4.5M
Total Liabilities & Shareholders Equity3.21M3.04M4.02M5.41M4.21M4.64M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our MEDPACE HLDGS financial analysis

The latest Protea Biosciences stock price, and Protea Biosciences historical stock prices show the stock price movement over time, and the Protea Biosciences PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: PRGBQ total assets, which was at $3.21M for 2016 is a balance sheet item representing value of what Protea Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Protea Biosciences is $17.31M. Shareholders' equity comes under liabilities as it is money the company owes the holders of PRGBQ stock.

Protea Biosciences Balance Sheet - Key Ratios

Annual Balance Sheets For Protea Biosciences Group Inc Peers

Aspyra balance sheet, Medical Connections balance sheet, MEDPACE HLDGS balance sheet